WHO ARE WE?
WHAT DO WE DO?
We are a science-driven startup with the desire of transforming Drug Design and Discovery Standards.
DRUGITT is an innovative and dynamic team of computational biochemists, computer scientists, Artificial Intelligence (AI) experts and business executives working together to develop exciting biomolecular technologies. We are passionate about providing the desired level of accuracy and speed to accelerate drug discovery efforts with a vision of improving human life.
We strive to develop out-of-the-box technologies at the interface of Biocience and Artificial Intelligence.
DRUGITT utilizes a combination of biophysics, chemistry, data science, computer science and artificial intelligence to study drug discovery process with a particular focus on the protein-ligand binding. As part of our research, we develop high-end products for each step of the process with the possibility to benefit separately or combined which are compatible with scientific workflows like KNIME.